BioCentury
ARTICLE | Clinical News

ME-344: Phase I start

April 16, 2012 7:00 AM UTC

Next month, Marshall Edwards will begin an open-label, dose-escalation Phase I trial to evaluate once-weekly 1.2, 2.5, 5, 10 and 20 mg/kg IV ME-344 in up to 24 patients. ...